Articles related to Internal Medicine

Adverse events from compounded semaglutide have led to hundreds of hospitalizations, highlighting critical safety concerns for healthcare providers managing patients seeking weight loss solutions.

The FDA-designated Class II recall affects specific duloxetine lots where exposure may lead to “temporary or medically reversible health consequences or where the probability of serious adverse health consequences is remote.”

The modified Johns Hopkins procedure demonstrates how robotic assistance can enhance surgical precision through small incisions, potentially reducing trauma and accelerating recovery in suitable pancreatic cancer patients.

Analysis of 285,680 patients shows a 1.03-1.38% reduction in cumulative mortality with rosuvastatin compared to atorvastatin, alongside varying risks for cardiovascular events, liver outcomes, and diabetes.

Current evidence indicates that while digestive and energy improvements may manifest within one week, longer-term benefits require extended supplementation periods and careful monitoring of iodine levels.

The WHO notes significant diagnostic challenges in differentiating Lassa fever from similar viral infections due to varied and non-specific presentation.